In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Ben Weintraub, the President of InThought Research and Doug Foster, Creator of the inVision software. inThought Research is a leading pharmaceutical and life science consulting firm providing analytical, forecasting, and competitive intelligence services to support strategic and tactical decisions of biopharmaceutical and financial firms. inVision is aimed at offering clients a streamlined interface for their business...

Today Dr Andree Bates talks to Patricia Gall, Founder and CEO of MindSpark 360, about the organisation's pivotal role in advancing mental health innovation.   MindSpark 360 operates as a structured programme, fostering open communication among all stakeholders in the mental health sector. Whether collaborating with corporations prioritising employee well-being or partnering with organisations driving new technologies and treatments for patients, MindSpark360 aims to facilitate sustainable...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Eunice Wu, Co-Founder and CEO of Asepha. Asepha helps Pharmacies to work efficiently and faster through specific and intelligent tests on their AI models. Eunice explains the potential of AI in revolutionising pharmacy operations and patient care, particularly through improved speed and accuracy in repetitive tasks.   Eunice points out the value of context in AI produced results and the bridge between current and...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by haemato-oncologist Niamh Boyle, who works in the Health Economic Evaluation of Precision Medicine in Cancer research project, University of South Wales.   Andree and Niamh discuss the use of AI in research methodologies and processes related to precision oncology. They also talk about how Health Technology Appraisal (HTA) bodies, such as the National Institute for Health and Care Excellence (NICE) implement and analyse AI...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Liam Kaufman, Vice President of Cambridge Cognition.   Andree and Liam talk about the use of AI during Central Nervous System (CNS) clinical research trials. They delve into how brain health and neural pathways can be explored and analysed, solely with the use of modern scientific technology.   Cambridge Cognition’s work has been pivotal in CNS examination and treatment. Liam explains how far investigative methods in...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Patrick Henz, Head of Governance Risk and Compliance at Primetals Technologies USA.   In this episode, Andree and Patrick discuss the relevance and implementation of AI in compliance and risk. They explore the ethics and complexities of this practice by individuals and big corporations, as well as the responsibilities of those using generative AI, which is becoming increasingly autonomous.   Addressing the key issues of...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Dr Michelle Oyen, Associate Professor of Biomedical Engineering at Washington University in St.Louis.    Michelle discusses the use and importance of AI in the field of maternal and fetal health. When an unexpected source changes Michelle’s career trajectory, she used her engineering background to research computational models to gather information related to pregnancy and childbirth.    Michelle and her team have...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Hon Weng Chong, M.D., the founder of Cortical Labs. They discuss the inception of Cortical Labs and how the company is responsible for the creation of DishBrain, a powerful computational neuron system using human brain cells. Eventually, this cellular neuron system became so adaptive and responsive, it learned how to play the classic video game Pong.   Beginning with the use of mouse brain cells, the development and...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Patrick Glinski and Ryan Brotman, the co-founders of Composehealth.ai. They discuss the use of artificial intelligence to automate the creation of an accurate content compliance review process, ready for use by individuals and businesses.   Compose Health is an AI platform that gives its users a precise method of drafting and generating pharma content that is suitable for mandatory compliance laws. Their platform...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Ari Caroline, CEO of Weave Bio, to discuss how the company is using artificial intelligence to streamline the IND application process for new therapeutics.   Weave Bio has developed an AI-powered platform that aims to cut the typical four month IND drafting time in half by automatically generating initial drafts of IND applications using supporting data and reports provided by users. The platform also helps organise data...

In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Manny Nsien, MHA the CEO of Ripple Ranch, an addiction treatment centre located in Texas.   They talk about how artificial intelligence can be leveraged to more precisely diagnose those suffering from addiction earlier by analysing various streams of patient data, including information from medical records, wearable devices, genetics testing, and more.   Additionally, they discuss how AI is being applied to personalise...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Emanuel Rose to talk about Authentic Marketing in the Age of AI.   You will learn how 51% of marketers are now using AI and various ways it's being used, including for copywriting, creative support, and data analysis. Emanuel discusses using AI in marketing while maintaining authenticity and emphasising brand voice, content calendars, and human input. Common mistakes like overreliance on AI without editing are covered....

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Greg Woolf of AI Think Tank to discuss managing cybersecurity risks with AI in the pharmaceutical industry.   Greg draws from his experience launching AI companies to discuss the growing $10 trillion cybercrime industry. He addressed threats facing healthcare like ransomware and identity theft exploiting medical data breaches. Greg also covers challenges of reliability, bias and other risks with AI systems. However, he...

In this episode of AI For Pharma Growth, Dr Andree Bates discusses SQREEM Technologies with Ian Chapman-Banks. SQREEM uses AI to analyse digital behaviours of healthcare professionals, helping pharmaceutical companies better engage this audience.   SQREEM has developed advanced algorithms and one of the largest datasets on probabilistic healthcare professional profiles globally. The discussion provides insights into how SQREEM personalised marketing and ad targeting for professional...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Jonathan Green who is an expert at using artificial intelligence tools to accelerate online business. He is the Best Selling Author of chat GPT Profits, and has a mailing list of over 100,000 subscribers.   They talk about how generative AI is revolutionising digital marketing and how it can be used for tasks like content creation, data analysis, and customer engagement. Jonathan discusses how he uses AI tools like...

In this episode of AI For Pharma Growth, host Dr Andree Bates interviews Sani Abdul-Jabbar, CEO of VezTek USA, a technology consulting firm.   He has over 20 years of experience helping startups bring emerging technologies like AI and blockchain to market faster. He discusses his background and how VezTek supports clients. Sani also shares his insights on recent advancements in machine learning and blockchain, as well as predictions for industries like healthcare, fintech and beyond.   In...

In this episode of AI For Pharma Growth, host Dr Andree Bates talks with Eric McHugh, president of SHOPX, to discuss opportunities at the intersection of generative AI and web3 for pharmaceutical companies. Eric explains how blockchain technologies like non-fungible tokens (NFTs) can help authenticate drugs and medical records to prevent counterfeiting. He also explores how patient data on the blockchain could help AI systems identify new treatment patterns and target drug development. Eric...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Casper Wilstrup, founder and CEO of Abzu.   They discuss how Abzu's QLattice Explainable AI algorithm can be used to accelerate disease understanding, drug design, and insights in pharma R&D. Casper explains how the QLattice generates hypotheses to explain phenomena using symbolic AI without requiring large datasets.    They explore applications in areas like biomarkers, RNA therapeutics, and reducing drug...

In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Piet Buyck, CEO and founder of Garvis AI.   He talks about how the company's AI system provides significantly more accurate demand forecasting for pharmaceutical companies. Piet explains that Garvis AI leverages different data sources and AI techniques to separately forecast demand for various elements, reducing errors by up to 30% compared to traditional methods.    In this episode you will learn: How traditional...

Dr. Andree Bates interviewed Alexander De Ridder, co-founder and CTO of SmythOS, to discuss how their AI agent platform can help pharmaceutical companies scale up their businesses.   Alexander explained that SmythOS allows users to orchestrate intelligent agents that can automate workflows, analyse complex datasets, and augment human work. The agents can collaborate to complete tasks like research, writing, and marketing. By tapping into available AI models and APIs, the agents are able to...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Saikiran Chandha, founder of SciSpace.   Saikiran discusses how SciSpace uses AI to help researchers save time on literature reviews and writing. SciSpace has developed tools using large language models to summarise papers, generate citations, and paraphrase text while maintaining the desired tone. Saikiran explains how researchers can upload their own papers and use SciSpace's AI capabilities on the full text. The...

In this episode of AI For Pharma Growth, Dr Andree Bates talks about the state of AI in biopharma, with a specific focus on how it is being applied across the value chain from research and development to business development, licensing, and clinical trials.   She discusses how AI can help accelerate drug discovery by analysing vast amounts of data, generate new drug candidates through machine learning, and help design and optimise clinical trials. Real-world examples of AI being used for...

In this episode of AI For Pharma Growth, Dr Andree Bates interviews Alice Yu and Mena Abdelsayed, co-founders of OncoCardia.   They discuss how their company uses artificial intelligence and stem cell technology to redesign drugs to be safer and more effective. They aim to reduce the time it takes to develop new drugs from almost a decade to just days or weeks.   OncoCardia leverages AI to predict safer drug analogues and their synthesis routes. Their stem cell platform also allows for...

In this episode of AI For Pharma Growth Dr Andree Bates is joined by Mark Benthin, Founder, CEO and Executive Chairman of ViiHealth to discuss how AI can be used to quickly engage HCPs and patients through personalising interactions with marketing content.   Mark discusses ViiHealth's use of generative AI to create personalised videos for physicians and patients using just one hour of recorded content from the person. He explains how this approach increases engagement rates, click through...